Dr Lal Path Labs needs volume growth to clear its FY27 tests
Subscribe to enjoy similar stories.Diagnostics major Dr. Lal Path Labs saw revenue improve 17% year-on-year to ₹703 crore in the March quarter (Q4FY26), beating consensus estimate by 5%. The jump was primarily led by higher sample volumes and better realizations.Revenue grew 12.2% to ₹2,763 crore in FY26.
Sample volumes rose around 13% in Q4FY26 aided by demand rather than pricing tailwinds. Diagnostics is ultimately a scale business, so a sustainable volume growth is crucial rather than just price increases. For FY27, management eyes early-to-mid-teens revenue growth driven by volumes and case mix rather than pricing.
This growth will be supported by a fairly aggressive expansion plan of 12–15 new laboratories, one to two high-end radiology centres, and a dedicated precision diagnostics lab, with a capital expenditure outlay of ₹100–120 crore.Over the last two years, the company has added around 32 labs, bringing the total to 312, and 2,000 collection centres, bringing the total to 7,727 as of FY26. These are now entering a more mature phase, where utilisation and, therefore, operating leverage should improve. Geography-wise, it has established a strong presence in Delhi, National Capital Region (NCR) and is gearing to drive the next leg of growth by going deeper in the core markets of north India and expanding its footprint in south and west India.
Read on livemint.com